Proteins and Peptides
18 April 2014
Molecular Templates Presents Preclinical Data on Engineered Toxin Bodies (ETBs) at the AACR Annual Meeting16 April 2014
GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)10 April 2014
Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone(R) Lispro3 April 2014
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease31 March 2014
Halozyme Announces that Consistent 1 Trial Of Hylenex® Recombinant Met Primary Endpoint31 March 2014
rEVO Biologics Inc. Initiates PRESERVE-1 Phase 3 Clinical Trial for ATryn® in Early-Onset Preeclampsia28 March 2014
Novartis to work with FDA on path forward for RLX030 for acute heart failure following Advisory Committee outcome27 March 2014
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports